Alembic Pharmaceuticals reports consolidated net loss of Rs 66 crore in Q1

05 Aug 2022 Evaluate

Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2022.

The company has reported a fall of 62.40% in its net profit at Rs 72.46 crore for the quarter under review as compared to Rs 192.69 crore for the same quarter in the previous year. Total income of the company decreased by 8.86% at Rs 1,160.95 crore for Q1FY23 as compared Rs 1,273.85 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported net loss after taxes, non-controlling interests and share of Loss of Associates and Joint Ventures of Rs 65.88 crore for the quarter under review as compared to net profit of Rs 164.52 crore for the same quarter in the previous year. Total income of the company decreased by 5.03% at Rs 1,263.22 crore for Q1FY23 as compared Rs 1,330.08 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×